Compare COMBAT DRUGS with BDH INDUS. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

COMBAT DRUGS vs BDH INDUS. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    COMBAT DRUGS BDH INDUS. COMBAT DRUGS/
BDH INDUS.
 
P/E (TTM) x 21.7 12.0 181.0% View Chart
P/BV x 4.9 1.8 273.6% View Chart
Dividend Yield % 0.0 2.3 -  

Financials

 COMBAT DRUGS   BDH INDUS.
EQUITY SHARE DATA
    COMBAT DRUGS
Mar-21
BDH INDUS.
Mar-21
COMBAT DRUGS/
BDH INDUS.
5-Yr Chart
Click to enlarge
High Rs41114 36.1%   
Low Rs1854 33.6%   
Sales per share (Unadj.) Rs55.099.7 55.2%  
Earnings per share (Unadj.) Rs1.411.0 12.6%  
Cash flow per share (Unadj.) Rs2.212.4 17.7%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Avg Dividend yield %03.6 0.0%  
Book value per share (Unadj.) Rs13.674.8 18.1%  
Shares outstanding (eoy) m10.105.76 175.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.50.8 64.0%   
Avg P/E ratio x21.37.6 280.7%  
P/CF ratio (eoy) x13.46.7 199.1%  
Price / Book Value ratio x2.21.1 194.8%  
Dividend payout %027.2 0.0%   
Avg Mkt Cap Rs m298482 61.9%   
No. of employees `000NANA-   
Total wages/salary Rs m47363 756.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m556575 96.7%  
Other income Rs m613 49.6%   
Total revenues Rs m562588 95.7%   
Gross profit Rs m3585 40.9%  
Depreciation Rs m88 103.8%   
Interest Rs m123 414.9%   
Profit before tax Rs m2187 24.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m724 31.0%   
Profit after tax Rs m1464 22.1%  
Gross profit margin %6.314.8 42.3%  
Effective tax rate %34.527.3 126.6%   
Net profit margin %2.511.1 22.8%  
BALANCE SHEET DATA
Current assets Rs m225505 44.6%   
Current liabilities Rs m173269 64.2%   
Net working cap to sales %9.441.1 22.9%  
Current ratio x1.31.9 69.4%  
Inventory Days Days770 26,509.8%  
Debtors Days Days766965 79.4%  
Net fixed assets Rs m161204 79.2%   
Share capital Rs m10159 170.1%   
"Free" reserves Rs m36371 9.7%   
Net worth Rs m137431 31.8%   
Long term debt Rs m670-   
Total assets Rs m387709 54.5%  
Interest coverage x2.832.0 8.8%   
Debt to equity ratio x0.50-  
Sales to assets ratio x1.40.8 177.3%   
Return on assets %6.79.4 71.0%  
Return on equity %10.214.8 69.4%  
Return on capital %16.221.0 77.5%  
Exports to sales %052.0 0.0%   
Imports to sales %035.7 0.0%   
Exports (fob) Rs mNA299 0.0%   
Imports (cif) Rs mNA205 0.0%   
Fx inflow Rs m0299 0.0%   
Fx outflow Rs m0205 0.0%   
Net fx Rs m094 0.0%   
CASH FLOW
From Operations Rs m188 233.7%  
From Investments Rs m-313 -24.4%  
From Financial Activity Rs m40-24 -163.6%  
Net Cashflow Rs m55-4 -1,504.6%  

Share Holding

Indian Promoters % 0.0 49.7 -  
Foreign collaborators % 45.9 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 54.1 50.3 107.4%  
Shareholders   12,796 5,086 251.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare COMBAT DRUGS With:   GLENMARK LIFE SCIENCES  FERMENTA BIOTECH  AMI ORGANICS  KABRA DRUGS  GODAVARI DRU  



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

COMBAT DRUGS SHARE PRICE


Dec 3, 2021 (Close)

TRACK COMBAT DRUGS

  • Track your investment in COMBAT DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMBAT DRUGS - AMI ORGANICS COMPARISON

COMPARE COMBAT DRUGS WITH

MARKET STATS